AU2001262141A1 - Use of CDP-choline for the treatment of alcohol withdrawal syndrome - Google Patents

Use of CDP-choline for the treatment of alcohol withdrawal syndrome

Info

Publication number
AU2001262141A1
AU2001262141A1 AU2001262141A AU2001262141A AU2001262141A1 AU 2001262141 A1 AU2001262141 A1 AU 2001262141A1 AU 2001262141 A AU2001262141 A AU 2001262141A AU 2001262141 A AU2001262141 A AU 2001262141A AU 2001262141 A1 AU2001262141 A1 AU 2001262141A1
Authority
AU
Australia
Prior art keywords
cdp
choline
treatment
alcohol withdrawal
withdrawal syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2001262141A
Other versions
AU2001262141B2 (en
Inventor
Julian Agut
Josep M. Castello
Rafael Foguet
Rafael Lozano
Jose A. Ortiz
Manuel M. Raga
Jorge Ramentol
Jesus Torres
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferrer Internacional SA
Original Assignee
Ferrer Internacional SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200000765A external-priority patent/ES2170649B1/en
Application filed by Ferrer Internacional SA filed Critical Ferrer Internacional SA
Publication of AU2001262141A1 publication Critical patent/AU2001262141A1/en
Application granted granted Critical
Publication of AU2001262141B2 publication Critical patent/AU2001262141B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2001262141A 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome Ceased AU2001262141B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ESP200000765 2000-03-29
ES200000765A ES2170649B1 (en) 2000-03-29 2000-03-29 USE OF CDP-HILL IN THE TREATMENT OF ALCOHOLIC ABSTINENCE.
PCT/EP2001/003536 WO2001072288A2 (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Publications (2)

Publication Number Publication Date
AU2001262141A1 true AU2001262141A1 (en) 2001-12-20
AU2001262141B2 AU2001262141B2 (en) 2005-03-10

Family

ID=8492914

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2001262141A Ceased AU2001262141B2 (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome
AU6214101A Pending AU6214101A (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU6214101A Pending AU6214101A (en) 2000-03-29 2001-03-28 Use of cdp-choline for the treatment of alcohol withdrawal syndrome

Country Status (21)

Country Link
US (1) US6894032B2 (en)
EP (1) EP1267892B1 (en)
JP (1) JP4724348B2 (en)
KR (1) KR100794891B1 (en)
AT (1) ATE281172T1 (en)
AU (2) AU2001262141B2 (en)
BR (1) BR0109477A (en)
CA (1) CA2402707C (en)
CZ (1) CZ298933B6 (en)
DE (1) DE60106890T2 (en)
DK (1) DK1267892T3 (en)
ES (1) ES2170649B1 (en)
IL (2) IL151163A0 (en)
MX (1) MXPA02009442A (en)
NO (1) NO329766B1 (en)
NZ (1) NZ520825A (en)
PL (1) PL199291B1 (en)
PT (1) PT1267892E (en)
RU (1) RU2251422C2 (en)
WO (1) WO2001072288A2 (en)
ZA (1) ZA200206349B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068104A1 (en) 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders
CA2492725A1 (en) * 2002-07-11 2004-01-22 Yamasa Corporation Medicinal composition for drug-induced neuropathy
JP4667041B2 (en) 2002-11-08 2011-04-06 ザ マクレーン ホスピタル コーポレーション Compounds for the treatment of tobacco dependence and withdrawal symptoms
AU2003299715A1 (en) * 2002-12-20 2004-07-22 The Mclean Hospital Corporation Compounds for the normalization of the sleep/wake cycle
JP2007508315A (en) * 2003-10-08 2007-04-05 ザ マクレーン ホスピタル コーポレーション Methods for treating mental disorders, substance abuse disorders, and other disorders using combinations comprising omega-3 fatty acids
EP1765075A4 (en) 2004-06-10 2010-11-10 Mclean Hospital Corp Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
WO2006020703A1 (en) 2004-08-11 2006-02-23 The Mclean Hospital Corporation Compounds for the treatment of marihuana dependence, withdrawal, and usage

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5308627A (en) * 1990-08-07 1994-05-03 Umbdenstock Jr Anthony J Nutritional supplement for optimizing cellular health
DE4342173A1 (en) * 1993-12-10 1995-06-14 Lohmann Therapie Syst Lts Pharmaceutical formulation for the prophylaxis or pretreatment of poisoning by organophosphorus cholinesterase inhibitors
CN101066276A (en) * 1994-07-01 2007-11-07 威尔斯塔特医疗公司 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
KR100217488B1 (en) * 1997-06-03 1999-09-01 맹섭 Head cover golf club
US5958896A (en) * 1997-08-08 1999-09-28 The Mclean Hospital Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
WO2001068104A1 (en) * 2000-03-16 2001-09-20 The Mclean Hospital Corporation Compounds for the treatment of psychiatric or substance abuse disorders

Similar Documents

Publication Publication Date Title
AU2002218462A1 (en) Thermal treatment system
AU2001295503A1 (en) Composition for the elimination of autoreactive b-cells
AU2001288462A1 (en) Medical instrument
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU2001267064A1 (en) Surgical table
AU2002214031A1 (en) System for withdrawing blood
AUPQ867900A0 (en) Medical injector system
AU2001241963A1 (en) Improved medical procedure
AU2001279178A1 (en) Topsheet for absorbent articles
MXPA03005731A (en) Absorbent article having releasable medicinal treatments.
AU2001271583A1 (en) Absorbent article tablet
AU4439701A (en) Patient support
AU2001280598A1 (en) Anti-occlusion catheter
AU2001259702A1 (en) Tissue regrafting
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2001281275A1 (en) Processes for the preparation of oligonucleotides
AU2001290165A1 (en) Components of canola for the treatment of cancer
AU2002242904A1 (en) Skin treatment comprising alcohol spirit
AU7431901A (en) Coherence-free cache
AU2001273762A1 (en) Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols
AU2001293891A1 (en) New combination for the treatment of asthma
HK1051692A1 (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain.
AU2001253165A1 (en) Use of fluorocarbons for the prevention of surgical adhesions
AU2001264631A1 (en) Medical instrument
AU2001262141A1 (en) Use of CDP-choline for the treatment of alcohol withdrawal syndrome